Medications

Wegovy: What you need to know about this weight loss drug

A much-hyped weight-loss jab will soon go on sale at high street chemists in the UK. Although a prescription will still be needed from a doctor to buy the drug, the news will no doubt be welcome to the many millions of people ...

Ophthalmology

FDA approves first treatment for geographic atrophy

Pegcetacoplan (SYFOVRE) has been approved by the U.S. Food and Drug Administration as the first and only treatment for geographic atrophy (GA), an advanced form of age-related macular degeneration.

Diseases, Conditions, Syndromes

Symptom and viral rebound uncommon after untreated COVID-19 infection

An analysis of a COVID-19 trial has found that a combination of symptoms and viral rebound after untreated COVID-19 infection is rare, occurring in only 3% of study participants. The analysis is published in Annals of Internal ...

Gerontology & Geriatrics

Ad26.RSV.preF-RSV preF protein vaccine immunogenic in seniors

An adenovirus serotype 26 respiratory syncytial virus (RSV) vector encoding a prefusion F (preF) protein (Ad26.RSV.preF) in combination with RSV preF protein is immunogenic and prevents RSV-mediated lower respiratory tract ...

Medications

Tackling skin inflammation with vitamin D

High-dose oral vitamin D reduced skin inflammation and increased immunoprotection in patients with chemical-induced skin rashes, according to findings from a recent Northwestern Medicine clinical trial published in JCI Insight.

Psychology & Psychiatry

Decaf kills coffee withdrawal symptoms

Coffee drinkers can take advantage of a new placebo discovery showing decaffeinated coffee quenches withdrawal symptoms in people reliant on their daily caffeine fix.

page 15 from 40